Artiva Biotherapeutics (ARTV) Current Leases (2023 - 2026)
Artiva Biotherapeutics (ARTV) reported Current Leases of $11000.0 for Q1 2026, down 99.69% year-over-year from $3.6 million in Q1 2025, and down 75.0% quarter-over-quarter from $44000.0 in Q4 2025.
Artiva Biotherapeutics (ARTV) Current Leases (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has 4 years of Current Leases data on file, last reported at $11000.0 in Q1 2026.
- Current Leases for Q1 2026 came in at $11000.0, down 99.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $11000.0 (down 99.69% YoY), and the FY2025 annual result was $44000.0, down 63.93% from the prior year.
- Current Leases retreated to $11000.0 in Q1 2026 per ARTV's latest filing, from $44000.0 in the prior quarter.
- Over five years, Current Leases peaked at $3.7 million in Q2 2024 and troughed at $11000.0 in Q1 2026.
- A 4-year average of $2.4 million and a median of $3.5 million in 2025 frame the typical range for Current Leases.
- The sharpest annual moves came in 2025 and 2026: Current Leases slipped 3.76% in 2025, then tumbled 99.69% in 2026.
- A 4-year view of Current Leases shows it stood at $3.6 million in 2023, then slumped by 96.61% to $122000.0 in 2024, then plunged by 63.93% to $44000.0 in 2025, then sank by 75.0% to $11000.0 in 2026.
- Business Quant data shows ARTV's Current Leases at $11000.0 in Q1 2026, $44000.0 in Q4 2025, and $3.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Artiva Biotherapeutics | 241.85 Mn | 241.85 Mn | - | 11,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11,000.00 |
| Dec 31, 2025 | 44,000.00 |
| Sep 30, 2025 | 3.10 Mn |
| Jun 30, 2025 | 3.54 Mn |
| Mar 31, 2025 | 3.59 Mn |
| Dec 31, 2024 | 122,000.00 |
| Sep 30, 2024 | 3.61 Mn |
| Jun 30, 2024 | 3.67 Mn |
| Dec 31, 2023 | 3.60 Mn |